The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Cost of illness of inflammatory bowel disease in the UK: a single centre retrospective study
Open accessAbstract
Background and aims: The potentially high costs of care associated with inflammatory bowel disease (IBD) are recognised but we have little knowledge of the scale, profile, or determinants of these costs in the UK. This study aimed to describe costs of illness for a group of IBD patients and determine factors associated with increased healthcare costs. Setting: A university hospital serving a target population of approximately 330 000. Patients and methods: A six month cohort of IBD patients receiving any form of secondary care was identified, comprising 307 cases of ulcerative (or indeterminate) colitis and 172 cases of Crohn’s disease. Demographic and clinical data were abstracted from clinical records and individual resource use was itemised for all attributable costs (including extraintestinal manifestations). Item costs were derived from national and local sources. Cost data were expressed as mean six month costs per patient (with 95% confidence interval (CI)) obtained using non-parametric bootstrapping. Determinants of cost were analysed using generalised linear regression modelling. A postal survey of patients was undertaken to examine indirect costs, out of pocket expenses, and primary care visits. Results: Inpatient services (medical and/or surgical) were required by 67 patients (14%) but accounted for 49% of total secondary care costs. Drug costs accounted for less than a quarter of total costs. Individual patient costs ranged from £73 to £33 254 per six months. Mean (95% CI) six month costs per patient were £1256 (£988, £1721) for colitis and £1652 (£1221, £2239) for Crohn’s disease. Hospitalisation, disease severity grade, and disease extent correlated positively with cost of illness but costs were independent of age or sex. Compared with quiescent cases of IBD, disease relapse was associated with a 2–3-fold increase in costs for non-hospitalised cases and a 20-fold increase in costs for hospitalised cases. Survey data suggested average six month costs were <£30 per patient for primary care visits (both diseases) and median loss of earnings were £239 for colitis and £299 for Crohn’s disease. Conclusions: This study represents the first detailed characterisation of the scale and determinants of costs of illness for IBD in a British hospital. Hospitalisation affected a minority of sufferers but accounted for half of the total direct costs falling on the healthcare system.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(1990) · Choice Reviews Online · doi:10.5860/choice.27-3338 · Cited by 35,305
Hosmer, D. W., & Lemeshow, S. (2000) · doi:10.1002/0471722146 · Cited by 20,302
An Analysis of Transformations
Box, G. E. P., & Cox, D. R. (1964) · Journal of the Royal Statistical Society Series B: Statistical Methodology · doi:10.1111/j.2517-6161.1964.tb00553.x · Cited by 15,052
Bootstrap Methods and their Application
Davison, A. C., & Hinkley, D. V. (1997) · doi:10.1017/cbo9780511802843 · Cited by 7,350
Bootstrap Methods and Their Application
Loughin, T. M., Davison, A. C., & Hinkley, D. V. (1999) · Journal of the American Statistical Association · doi:10.2307/2669707 · Cited by 5,418
Estimation with Heteroscedastic Error Terms
Park, R. E. (1966) · Econometrica · doi:10.2307/1910108 · Cited by 426
Regression and ANOVA with Zero-One Data: Measures of Residual Variation
Efron, B. (1978) · Journal of the American Statistical Association · doi:10.1080/01621459.1978.10480013 · Cited by 360
Silverstein, M. D., Loftus, E. V., Sandborn, W. J., Tremaine, W. J., Feagan, B. G., Nietert, P. J., Harmsen, W. S., & Zinsmeister, A. R. (1999) · Gastroenterology · doi:10.1016/s0016-5085(99)70549-4 · Cited by 354
Inflammatory bowel disease: epidemiology and management in an English general practice population
Rubin, G. P., Hungin, A. P. S., Kelly, P. J., & Ling, J. (2000) · Alimentary Pharmacology & Therapeutics · doi:10.1046/j.1365-2036.2000.00886.x · Cited by 315
Guided self-management and patient-directed follow-up of ulcerative colitis: a randomised trial
Robinson, A., Thompson, D. G., Wilkin, D., & Roberts, C. (2001) · The Lancet · doi:10.1016/s0140-6736(01)06105-0 · Cited by 218
Longobardi, T. (2003) · The American Journal of Gastroenterology · doi:10.1016/s0002-9270(02)06007-0 · Cited by 196
Annual cost of care for Crohn's disease: a payor perspective
Feagan, B. (2000) · The American Journal of Gastroenterology · doi:10.1016/s0002-9270(00)01053-4 · Cited by 193
Inflammatory Bowel Diseases: Health Care and Costs in Sweden in 1994
Blomqvist, P., & Ekbom, A. (1997) · Scandinavian Journal of Gastroenterology · doi:10.3109/00365529709002993 · Cited by 160
Inflammatory bowel disease incidence: up, down or unchanged?
Logan, R. F. (1998) · Gut · doi:10.1136/gut.42.3.309 · Cited by 154
The Cost of Hospitalization in Crohn's Disease
Cohen, R. D., Larson, L. R., Roth, J., Becker, R. V., & Mummert, L. H. (2000) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2000.01779.x · Cited by 147
Boonen, A. E. R. C. H., Dagnelie, P. C., Feleus, A., Hesselink, M., Muris, J. W. M., Stockbrügger, R. W., & Rüssel, M. G. (2002) · Inflammatory Bowel Diseases · doi:10.1097/00054725-200211000-00002 · Cited by 120
Clinical economics review: medical management of inflammatory bowel disease
WARD, Bodger, K., DALY, & Heatley (1999) · Alimentary Pharmacology & Therapeutics · doi:10.1046/j.1365-2036.1999.00437.x · Cited by 105
Self-citationPrevalence and management of inflammatory bowel disease
Stone, M. A., Mayberry, J. F., & Baker, R. (2003) · European Journal of Gastroenterology & Hepatology · doi:10.1097/00042737-200312000-00004 · Cited by 104
Nightingale, A., Middleton, W., Middleton, S. J., & Hunter, J. O. (2000) · European Journal of Gastroenterology & Hepatology · doi:10.1097/00042737-200012090-00001 · Cited by 101
Longobardi, T., Jacobs, P., Wu, L., & Bernstein, C. N. (2003) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2003.07378.x · Cited by 99
Kennedy, A. P., Nelson, E. C., Reeves, D., Richardson, G. A., Roberts, C., Robinson, A., Rogers, A. E., Sculpher, M., & Thompson, D. (2003) · Health Technology Assessment · doi:10.3310/hta7280 · Cited by 96
Review of Generalized Linear Models and Extensions by Hardin and Hilbe
Newson, R. B. (2001) · The Stata Journal Promoting communications on statistics and Stata · doi:10.1177/1536867x0100100107 · Cited by 92
Cost of Illness of Crohn??s Disease
Bodger, K. (2002) · PharmacoEconomics · doi:10.2165/00019053-200220100-00001 · Cited by 89
Self-citationInflammatory Bowel Disease in Northern Alberta
Pinchbeck, B., Kirdeikis, J., & Thomson, A. B. R. (1988) · Journal of Clinical Gastroenterology · doi:10.1097/00004836-198810000-00007 · Cited by 82
Williams, J. G. (2000) · BMJ · doi:10.1136/bmj.320.7234.544 · Cited by 80
Patients consulting with Crohnʼs disease in primary care in England and Wales
Thompson, N., Fleming, D., Charlton, J. R. H., et al. (1998) · European Journal of Gastroenterology & Hepatology · doi:10.1097/00042737-199812000-00005 · Cited by 34
Rösch, M., Leidl, R., von Tirpitz, C., Reinshagen, M., Adler, G., & König, H. ‐. (2002) · Zeitschrift für Gastroenterologie · doi:10.1055/s-2002-25153 · Cited by 30
Guided Self-Management and Patient-Directed Follow-up of Ulcerative Colitis: A Randomised Trial
Braegger, C. (2002) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1097/00005176-200204000-00026 · Cited by 21
Ragunath, K., Williams, J. G., Cheung, W., Rahman, M. M., Russell, I. T., Cohen, D. R., Longo, M., & Lervy, B. (2000) · Gastroenterology · doi:10.1016/s0016-5085(00)85019-2 · Cited by 12
Stone, M., Mayberry, J. F., & Baker, R. D. (2003) · Leicester Research Archive (University of Leicester) · doi:10.1097/01.meg.0000085500.01212.e2 · Cited by 10
Cited by
The burden of inflammatory bowel disease in Europe
Burisch, J., Jess, T., Martinato, M., & Lakatos, P. L. (2013) · Journal of Crohn's and Colitis · doi:10.1016/j.crohns.2013.01.010 · Cited by 961
Direct Health Care Costs of Crohn's Disease and Ulcerative Colitis in US Children and Adults
Kappelman, M. D., Rifas–Shiman, S. L., Porter, C. Q., Ollendorf, D. A., Sandler, R. S., Galanko, J. A., & Finkelstein, J. A. (2008) · Gastroenterology · doi:10.1053/j.gastro.2008.09.012 · Cited by 634
van der Valk, M. E., Mangen, M.-J. J., Leenders, M., Dijkstra, G., van Bodegraven, A. A., Fidder, H. H., de Jong, D. J., Pierik, M., van der Woude, C. J., Romberg-Camps, M. J. L., et al. (2014) · Gut · doi:10.1136/gutjnl-2012-303376 · Cited by 500
Feagan, B. G., Panaccione, R., Sandborn, W. J., D'Haens, G. R., Schreiber, S., Rutgeerts, P. J., Loftus, E. V., Lomax, K. G., Yu, A. P., Wu, E. Q., et al. (2008) · Gastroenterology · doi:10.1053/j.gastro.2008.07.069 · Cited by 374
Inflammatory Bowel Disease: An Expanding Global Health Problem
M'koma, A. E. (2013) · Clinical Medicine Insights: Gastroenterology · doi:10.4137/cgast.s12731 · Cited by 359
Metadata
- Authors
- Bassi, A., Dodd, S., Williamson, P., & Bodger, K.
- Venue
- Gut
- Publisher
- BMJ
- Published
- 2004-09-10
- Volume
- 53
- Issue
- 10
- Pages
- 1471-1478
- ISSN
- 0017-5749 (ISSN-L)
- 1468-3288
- OpenAlex
- W2134299051
- Cited by
- 309
- References
- 30
- FWCI
- 5.72
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.